EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of targeting methods on treatment outcome in rTMS for treatment resistant depression: Evidence gaps and considerations for the field

A. Coen Coomans, Lot V. de Roij, Eva Oostra, Adriaan W. Hoogendoorn, Ysbrand D. van der Werf, Odile A. van den Heuvel, Eric van Exel

Transcranial Magnetic Stimulation · 2026-12 · 9 · 100337

DOI: 10.1016/j.transm.2026.100337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transcranial Magnetic Stimulation, 2026-12. Verfasst von A. Coen Coomans und 6 weiteren Autor:innen. Die Arbeit nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for treatment-resistant depression (TRD), typically targeting the dorsolateral prefrontal cortex (DLPFC). Various methods for target localization exist. However, the clinical benefit of anatomically accurate targeting remains unclear.

Objective

This meta-analysis investigated the effect of different targeting methods on the therapeutic efficacy of rTMS in TRD.

Methods

We included 93 RCTs, yielding 120 unique comparisons of four targeting methods: the 5cm rule, 6cm rule, F3-based targeting, and MRI-based neuronavigation. The primary outcome was standardized mean difference (SMD) in depression severity from pre- to post-treatment. Random-effects meta-regressions and meta-analyses examined the impact of targeting method on treatment outcome.

Results

For all targeting methods, summary within effects were high, while no significant differences in efficacy were observed across targeting methods. The 5cm rule produced an effect of SMD=1.96 (95%CI[1.39,2.54]) on depressive symptoms and a heterogeneity of I²=91.3%. The 6cm rule demonstrated an effect of SMD=2.18 (95%CI[1.75,2.61]) with heterogeneity I²=79.2%. F3-based targeting showed SMD=1.87 (95%CI[1.13,2.61]) and heterogeneity I²=64.5%, and MRI-based neuronavigation assisted targeting showed SMD=2.12 (95%CI[1.14,3.10]) with heterogeneity I²=88.2%.

Conclusions

Within conventional stimulation protocols (1-20Hz), we found no evidence that any anatomical targeting method outperforms others in terms of clinical efficacy. However, firm conclusions are obstructed by widespread variation in stimulation protocol parameters between targeting subgroups. Variation in target definition limits reliable evidence for structural MRI-guided neuronavigation, whereas limited studies have employed functional MRI-guided neuronavigation in combination with conventional stimulation protocols.

Zitieren

APA

Coomans, A. C., Roij, L. V. D., Oostra, E., Hoogendoorn, A. W., Werf, Y. D. V. D., Heuvel, O. A. V. D., & Exel, E. V. (2026). The role of targeting methods on treatment outcome in rTMS for treatment resistant depression: Evidence gaps and considerations for the field. Transcranial Magnetic Stimulation, 9, 100337. https://doi.org/10.1016/j.transm.2026.100337

Vancouver

Coomans AC, Roij LVD, Oostra E, Hoogendoorn AW, Werf YDVD, Heuvel OAVD, et al. The role of targeting methods on treatment outcome in rTMS for treatment resistant depression: Evidence gaps and considerations for the field. Transcranial Magnetic Stimulation. 2026;9:100337. doi:10.1016/j.transm.2026.100337

BibTeX
@article{Coomans2026,
  author = {Coomans, A. Coen and Roij, Lot V. de and Oostra, Eva and Hoogendoorn, Adriaan W. and Werf, Ysbrand D. van der and Heuvel, Odile A. van den and Exel, Eric van},
  title = {The role of targeting methods on treatment outcome in rTMS for treatment resistant depression: Evidence gaps and considerations for the field},
  journal = {Transcranial Magnetic Stimulation},
  year = {2026},
  volume = {9},
  pages = {100337},
  doi = {10.1016/j.transm.2026.100337}
}
Kostenlos starten →